Assignee
KITE PHARMA INC
US·48 granted patents·79 pending applications·188 citations·filing 2016–2025
Top patents by PatentIndex Score
127 records- 0195US10626187B2Antigen binding molecules specific for an anti-CD19 scFvKITE PHARMA INC·Filed 2017·Granted Apr 21, 2020·8 cites·12 claims
- 0295US10603380B2Chimeric antigen and T cell receptors and methods of useKITE PHARMA INC·Filed 2017·Granted Mar 31, 2020·16 cites·27 claims
- 0395US10322146B2Methods of conditioning patients for T cell therapyKITE PHARMA INC·Filed 2017·Granted Jun 18, 2019·17 cites·30 claims
- 0495US9855298B2Methods of conditioning patients for T cell therapyKITE PHARMA INC·Filed 2016·Granted Jan 2, 2018·80 cites·30 claims
- 0593US10844120B2Humanized antigen-binding domains and methods of useKITE PHARMA INC·Filed 2018·Granted Nov 24, 2020·8 cites·15 claims
- 0692US10844371B2Antigen binding molecules and methods of use thereofKITE PHARMA INC·Filed 2018·Granted Nov 24, 2020·6 cites·9 claims
- 0790US11572388B2Chimeric polypeptides and uses thereofKITE PHARMA INC·Filed 2020·Granted Feb 7, 2023·2 cites·7 claims
- 0890US11384155B2Antigen binding molecules specific for an anti-CD19 scFvKITE PHARMA INC·Filed 2020·Granted Jul 12, 2022·2 cites·12 claims
- 0990US11046775B2CD70 binding molecules and methods of use thereofKITE PHARMA INC·Filed 2018·Granted Jun 29, 2021·9 cites·50 claims
- 1089US11779601B2Diagnostic methods for T cell therapyKITE PHARMA INC·Filed 2016·Granted Oct 10, 2023·5 cites·13 claims
- 1188US2025243295A1Antigen binding molecules and methods of use thereofKITE PHARMA INC·Filed 2024·Application pending·0 cites
- 1287US11491187B2Methods of conditioning patients for T cell therapyKITE PHARMA INC·Filed 2018·Granted Nov 8, 2022·2 cites·15 claims
- 1386US10597456B2Chimeric receptors and methods of use thereofKITE PHARMA INC·Filed 2017·Granted Mar 24, 2020·6 cites·46 claims
- 1485US11834654B2Antigen binding molecules and methods of use thereofKITE PHARMA INC·Filed 2020·Granted Dec 5, 2023·1 cites·5 claims
- 1585US2025367221A1Methods of conditioning patients for t cell therapyKITE PHARMA INC·Filed 2025·Application pending·0 cites
- 1684USD991483SCassette foam insertKITE PHARMA INC·Filed 2021·Granted Jul 4, 2023·10 cites·1 claims
- 1784US10501775B2Antigen binding molecules and methods of use thereofKITE PHARMA INC·Filed 2017·Granted Dec 10, 2019·6 cites·20 claims
- 1883US11723923B2Methods of preparing T cells for T cell therapyKITE PHARMA INC·Filed 2019·Granted Aug 15, 2023·2 cites·12 claims
- 1983US11608517B2Antigen binding molecules and methods of use thereofKITE PHARMA INC·Filed 2019·Granted Mar 21, 2023·2 cites·15 claims
- 2082US12583923B2Chimeric antigen and T cell receptors and methods of useKITE PHARMA INC·Filed 2024·Granted Mar 24, 2026·0 cites·29 claims
- 2182US2025243258A1Chimeric receptor t cell treatment using characteristics of the tumor microenvironmentKITE PHARMA INC·Filed 2024·Application pending·0 cites
- 2281US12458654B2Methods of conditioning patients for T cell therapyKITE PHARMA INC·Filed 2022·Granted Nov 4, 2025·0 cites·12 claims
- 2381US12404305B2Chimeric polypeptides and uses thereofKITE PHARMA INC·Filed 2022·Granted Sep 2, 2025·0 cites·4 claims
- 2481US12202909B2Antigen binding molecules specific for an anti-CD19 scFVKITE PHARMA INC·Filed 2022·Granted Jan 21, 2025·0 cites·9 claims
- 2581US2024158748A1Methods for producing autologous t cells useful to treat b cell malignancies and other cancers and compositions thereofKITE PHARMA INC·Filed 2023·Application pending·0 cites
- 2681US2025002851A1Methods of preparing t cells for t cell therapyKITE PHARMA INC·Filed 2024·Application pending·0 cites
- 2780US11390655B2Modified chimeric antigen receptors and methods of useKITE PHARMA INC·Filed 2018·Granted Jul 19, 2022·1 cites·6 claims
- 2879US11708401B2Chimeric transmembrane proteins and uses thereofKITE PHARMA INC·Filed 2019·Granted Jul 25, 2023·2 cites·20 claims
- 2979US10689450B2BCMA binding molecules and methods of use thereofKITE PHARMA INC·Filed 2017·Granted Jun 23, 2020·1 cites·71 claims
- 3078US2024009243A1Methods of preparing t cells for t cell therapyKITE PHARMA INC·Filed 2023·Application pending·0 cites
- 3177US12109235B2TGF-beta receptors and methods of useKITE PHARMA INC·Filed 2020·Granted Oct 8, 2024·1 cites·11 claims
- 3277US2024150750A1Antigen binding molecules and methods of use thereofKITE PHARMA INC·Filed 2023·Application pending·0 cites
- 3377US2025188177A1Cd70 binding molecules and methods of use thereofKITE PHARMA INC·Filed 2024·Application pending·0 cites
- 3476US12559718B2Diagnostic methods for t cell therapyKITE PHARMA INC·Filed 2023·Granted Feb 24, 2026·0 cites·30 claims
- 3575US11793834B2Chimeric antigen and T cell receptors and methods of useKITE PHARMA INC·Filed 2019·Granted Oct 24, 2023·1 cites·17 claims
- 3674US2024115611A1Chimeric antigen and t cell receptors and methods of useKITE PHARMA INC·Filed 2023·Application pending·0 cites
- 3773US12459979B2Modified chimeric antigen receptors and methods of useKITE PHARMA INC·Filed 2022·Granted Nov 4, 2025·0 cites·6 claims
- 3873US2022265721A1Treatment using chimeric receptor t cells incorporating optimized polyfunctional t cellsKITE PHARMA INC·Filed 2022·Application pending·0 cites
- 3973US2023331855A1Chimeric receptors and methods of use thereofKITE PHARMA INC·Filed 2023·Application pending·0 cites
- 4073US2024168016A1Flow cytometric method for characterization of t-cell impuritiesKITE PHARMA INC·Filed 2023·Application pending·0 cites
- 4173US2023146195A1Bcma binding molecules and methods of use thereofKITE PHARMA INC·Filed 2022·Application pending·0 cites
- 4271US11505613B2BCMA binding molecules and methods of use thereofKITE PHARMA INC·Filed 2019·Granted Nov 22, 2022·0 cites·22 claims
- 4370US12180292B2CD70 binding molecules and methods of use thereofKITE PHARMA INC·Filed 2021·Granted Dec 31, 2024·0 cites·17 claims
- 4469US2024058381A1Methods of administering chimeric antigen receptor immunotherapyKITE PHARMA INC·Filed 2023·Application pending·0 cites
- 4569US2025109182A1TGF-beta Receptors and Methods of UseKITE PHARMA INC·Filed 2024·Application pending·0 cites
- 4668US12156887B2Chimeric receptor T cell treatment using characteristics of the tumor microenvironmentKITE PHARMA INC·Filed 2019·Granted Dec 3, 2024·0 cites·6 claims
- 4768US2022249631A1Methods and systems for performing a patient-specific immunotherapy procedure with chain-of-custody and chain-of-identity biological sample trackingKITE PHARMA INC·Filed 2022·Application pending·0 cites
- 4867US2024091261A1Immune cell functionKITE PHARMA INC·Filed 2023·Application pending·0 cites
- 4967US2023270785A1Methods of administering chimeric antigen receptor immunotherapyKITE PHARMA INC·Filed 2023·Application pending·0 cites
- 5066US12480951B2Methods and compositions for T cell therapyKITE PHARMA INC·Filed 2022·Granted Nov 25, 2025·0 cites·15 claims
Showing the top 50 of 127 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when KITE PHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →